Particular areas of focus include: Sports Performance, Cardiovascular Wellness, Diabetes Education and management, Digestive health, and a body-positive approach to improving lean muscle mass and body composition
Distinctive Pharmacological Research Features Several characteristics distinguish BPC-157 from other research peptides commonly used in metabolic and cell-signaling research: No confirmed primary receptor: BPC-157s reported effects are associated with modulation of multiple signaling systems, including NO-related signaling, FAK-paxillin biology, VEGFR2-associated signaling, and endothelial responses, without a clearly identified primary molecular target
That's why we continue to recommend a DEXA scan before starting a GLP-1 medication whenever possible
Placebo-controlled superiority trials in type 2 diabetes (T2D) LEADER, SUSTAIN-6, REWIND, and SOUL and in obesity without diabetes (SELECT) demonstrated statistically significant reductions in major adverse cardiovascular events (MACE) of approximately 12%26% [3], [4], [10][12]